No Data
No Data
Noxopharm Ltd: Noxopharm enhances 2024 cash position via R&D rebate
ASX Small-Cap Stocks to Watch
Noxopharm Announces Key 2024 AGM Details
Noxopharm Taps Supplier for Autoimmune Diseases Drug Trial; Shares Down 4%
Noxopharm 'a Step Closer to the Clinic' Upon Signing Manufacturer for SOF-SKN Production
Noxopharm Ltd: Annual Report to shareholders
No Data
No Data